Cargando…

Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic disorders. This study aimed to explore the role of metabolic disorders in screening advanced fibrosis in NAFLD patients. METHODS: A total of 246 histologically-proven NAFLD patients were enrolled across 14 cen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yi-Wen, He, Fang-Ping, Chen, Jin-Jun, Deng, Hong, Shi, Jun-Ping, Zhao, Cai-Yan, Mi, Yu-Qiang, Zou, Zheng-Sheng, Zhou, Yong-Jian, Di, Fu-Sheng, Zheng, Rui-Dan, Du, Qin, Shang, Jia, Yang, Rui-Xu, Popovic, Branko, Zhong, Bi-Hui, Fan, Jian-Gao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516831/ https://www.ncbi.nlm.nih.gov/pubmed/34722175 http://dx.doi.org/10.14218/JCTH.2021.00058

Ejemplares similares

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022)

Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients
por: Milovanovic Alempijevic, Tamara, et al.
Publicado: (2017)

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)

Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
por: Hayashi, Tatsuya, et al.
Publicado: (2017)

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
por: Yang, Hye Ran
Publicado: (2013)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
por: Jayasekera, Dulshan, et al.
Publicado: (2023)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
por: Song, Do Seon, et al.
Publicado: (2019)

Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis
por: Dajani, Asad Izziddin, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Association between Noninvasive Fibrosis Markers and Chronic Kidney Disease among Adults with Nonalcoholic Fatty Liver Disease
por: Sesti, Giorgio, et al.
Publicado: (2014)

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
por: Johnson, Amy L., et al.
Publicado: (2021)

Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease
por: Cui, Ran, et al.
Publicado: (2013)

Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Han, Sangsoo, et al.
Publicado: (2022)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
por: Caussy, Cyrielle, et al.
Publicado: (2020)

Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease
por: Lee, Jiwoo, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
por: Zhou, Jiang-Hua, et al.
Publicado: (2019)

Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease
por: Zheng, Rui-Dan, et al.
Publicado: (2012)

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Qu, Ying, et al.
Publicado: (2021)

Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Hou, Wei, et al.
Publicado: (2020)

Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model
por: Shen, Fei-Fei, et al.
Publicado: (2018)

The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease
por: Isabela Andronescu, Craita, et al.
Publicado: (2018)

The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
por: Hernandez Roman, Jose, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
por: Bassal, Tamara, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysis
por: Zhou, Yao‐Yao, et al.
Publicado: (2018)

Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey
por: Huang, Rui, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center
por: Taranto, Daniela Oliveira de Lima, et al.
Publicado: (2020)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
por: Zhao, ChenLu, et al.
Publicado: (2023)

The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea
por: Ding, Haibo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_67v60mhk354nrr5pkgdkdcpuf1